Keyphrases
Genetic Modification
100%
Therapeutic Approaches
100%
Acute Megakaryoblastic Leukemia
100%
Xenograft Model
100%
Fusion Gene
60%
Molecular Subgroups
40%
Pediatric
20%
Novel Therapeutics
20%
Novel Therapies
20%
Down Syndrome
20%
Gene Signature
20%
Immunodeficient Mice
20%
Heterogeneous Disease
20%
GATA1 mutation
20%
Poor Prognosis
20%
Gene Expression Profile
20%
Trisomy 21
20%
Leukemic Cells
20%
Pathway Activation
20%
Aurora Kinase Inhibitor
20%
Limited Access
20%
Molecular Data
20%
Hedgehog Signaling Pathway
20%
Chromosome 16
20%
Preclinical Screening
20%
Screening Platform
20%
Xenotransplantation
20%
High-throughput RNA Sequencing
20%
Efficient Development
20%
NUP98 Fusion
20%
MLL Fusions
20%
CBFA2T3-GLIS2
20%
Biochemistry, Genetics and Molecular Biology
Fusion Gene
100%
Genomics
100%
Hedgehog Signaling Pathway
33%
NUP98
33%
Gene Expression Profiling
33%
GLIS2
33%
Gene Expression
33%
Gene Mutation
33%
Upregulation
33%
GATA1
33%
Chromosome 16
33%
Down Syndrome
33%
Deep Sequencing
33%
Trisomy 21
33%
Gene Cluster
33%
Aurora A Kinase
33%
Medicine and Dentistry
Xenograft
100%
Acute Megakaryoblastic Leukemia
100%
Fusion Gene
60%
Diseases
20%
Gene Expression
20%
Upregulation
20%
Gene Mutation
20%
Gene Cluster
20%
Gene Expression Profiling
20%
Phosphotransferase Inhibitor
20%
Down Syndrome
20%
RNA Sequence
20%
Chromosome 16
20%
Transcription Factor GATA 1
20%
Trisomy 21
20%
Xenotransplantation
20%
Pediatrics
20%
Aurora A Kinase
20%
Hedgehog Signaling
20%
Immunology and Microbiology
Xenograft
100%
Fusion Gene
100%
Hedgehog Signaling
33%
RNA Sequence
33%
Gene Expression
33%
Transcription Factor GATA 1
33%
Gene Mutation
33%
Upregulation
33%
Chromosome 16
33%
Xenotransplantation
33%
Gene Cluster
33%
Gene Expression Assay
33%
Pharmacology, Toxicology and Pharmaceutical Science
Acute Megakaryocytic Leukemia
100%
Hedgehog
20%
RNA-Sequencing
20%
Transcription Factor GATA 1
20%
Phosphotransferase Inhibitor
20%
Trisomy 21
20%
Disease
20%
Down Syndrome
20%
Aurora A Kinase
20%